Testing a Medication Risk Communication and Surveillance Strategy: The EMC2 Trial

8/15/2015 to 5/31/2019
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) / 1R01DK103684-01A1

About this Project

 We are assessing the effectiveness and fidelity of a primary care-based, technology-enabled strategy to improve patient-provider communication about prescribed, higher-risk medications to ensure safe use.

Principal Investigator